Opinion: A long journey to care, or why it’s time for an ambitious EU framework for a cross-border healthcare


Treatment Without Borders: The EU Case for Equitable Patient Access to Advanced Therapies


EuropaBio’s response to the EC consultation on patients’ rights in cross-border healthcare


EPSCO Council conclusions: EuropaBio calls for more pragmatic approach addressing access, availability and affordability of medicines


Advanced Therapies bring tranformational value to European patients


EuropaBio Response to Public Consultation on the Evaluation of Patient Rights in Cross-Border Healthcare

EuropaBio sees the Directive on cross-border healthcare as an important instrument to ensure patient access to the best available care. The Directive is particularly relevant for advanced therapies and medicines for rare diseases.

EuropaBio statement on European Parliament report on EU options for improving access to medicines

EuropaBio notes the adoption by the European Parliament of the report on EU options for improving patient access to medicines on 2 March 2017, in Brussels.